APA (7th ed.) Citation

Ippolito, G., Petrone, L., Niccoli, L., Nannini, C., Cantini, F., & Goletti, D. (2017). Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics. Mediators of inflammation, 2017(2017), 1-15. https://doi.org/10.1155/2017/8909834

Chicago Style (17th ed.) Citation

Ippolito, Giuseppe, Linda Petrone, Laura Niccoli, Carlotta Nannini, Fabrizio Cantini, and Delia Goletti. "Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics." Mediators of Inflammation 2017, no. 2017 (2017): 1-15. https://doi.org/10.1155/2017/8909834.

MLA (9th ed.) Citation

Ippolito, Giuseppe, et al. "Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics." Mediators of Inflammation, vol. 2017, no. 2017, 2017, pp. 1-15, https://doi.org/10.1155/2017/8909834.